<?xml version="1.0" encoding="UTF-8"?>
<ref id="B12-ijerph-17-04951">
 <label>12.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Akiyama</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>Lipsey</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Heo</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Agyemang</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Norton</surname>
    <given-names>B.L.</given-names>
   </name>
   <name>
    <surname>Hidalgo</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Lora</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Litwin</surname>
    <given-names>A.H.</given-names>
   </name>
  </person-group>
  <article-title>Low hepatitis C reinfection following direct-acting antiviral therapy among people who inject drugs on opioid agonist therapy</article-title>
  <source>Clin. Infect. Dis.</source>
  <year>2019</year>
  <pub-id pub-id-type="doi">10.1093/cid/ciz693</pub-id>
  <?supplied-pmid 31346609?>
  <pub-id pub-id-type="pmid">31346609</pub-id>
 </element-citation>
</ref>
